The best way to come off Mounjaro: what the evidence actually says

What trial evidence tells us about stopping tirzepatide

The clearest signal in the research is this: tirzepatide works while you take it, and much of that effect reverses when you stop. In the SURMOUNT-4 extension trial, participants who completed 36 weeks on tirzepatide and then switched to placebo for a further 52 weeks regained on average around two-thirds of the weight they had lost, a finding cited in NICE's technology appraisal of tirzepatide (TA1026) when assessing the medicine's long-term value. The biology behind that is consistent with how the medicine works: tirzepatide suppresses appetite through GIP and GLP-1 receptor pathways, and those signals stop when the drug clears your system. Your hunger signals return, often more forcefully than before, because body-weight regulation actively resists loss.

This isn't a reason to stay on the medicine indefinitely or to never stop. It is a reason to plan the exit carefully. Participants in SURMOUNT-4 who had built stronger lifestyle habits during active treatment fared better in the withdrawal period. The evidence points firmly toward treating the stopping phase as a structured transition, not a clean break.

If you want to understand more about the realistic weight-loss trajectory while you are on treatment, typical weight loss figures with Mounjaro give a useful baseline for that conversation with your prescriber.

Gradual reduction versus stopping abruptly: what prescribers tend to recommend

A question our prescribers hear most weeks is whether you need to taper Mounjaro down through the lower doses before stopping, or whether you can simply not order the next pen. The honest answer is that there is no single protocol mandated in the Mounjaro SmPC for tapering in the way there is for, say, steroid withdrawal. The NHS tirzepatide page is clear that stopping decisions belong to the prescriber.

In practice, what matters is the reason you are stopping. If you are stopping because treatment has achieved its goal and you feel ready, a gradual step-down through doses gives your appetite regulation more time to adjust and can soften the rebound in hunger. If you are stopping suddenly because of a side effect, pregnancy, an upcoming operation or another urgent clinical reason, an abrupt stop is sometimes necessary and your prescriber will advise on monitoring and next steps.

Stopping for a week or two (say, around a holiday or a short medical procedure) raises a different set of questions. Short pauses from Mounjaro are sometimes unavoidable, but the clinical considerations are distinct from a permanent stop, particularly around how your body re-adjusts when you restart. For anything beyond a couple of weeks, restart dosing should be discussed with your prescriber: they may need to return you to a lower dose.

The phrase "best way" implies a single answer. The more accurate framing is that the best approach is the one designed around you, your current dose, how long you have been on treatment, your weight-loss trajectory, and what comes next for your health.

Building the foundations that carry you through stopping

The trial evidence is blunt: lifestyle habits are the main buffer against regain after stopping. That is not a criticism of people who regain weight, it reflects the biology of a chronic condition. But it does point to where effort pays off during the stopping phase.

Protein adequacy matters more than most people expect. Tirzepatide reduces appetite broadly, which can lower protein intake without people noticing; on the way out of treatment, prioritising protein (lean meat, fish, eggs, dairy, legumes) helps preserve muscle mass and keeps satiety hormones working harder. Strength-based activity has a similar double benefit: it maintains lean tissue and nudges the metabolic rate in the right direction. Neither of these is complex, but both need to be deliberately maintained rather than assumed.

Meal structure (regular eating windows, managing ultra-processed food exposure, building in enough fibre) helps replace some of what the medicine was doing to regulate appetite rhythm. Again, none of this is a substitute for the medicine's pharmacological effect, but together these habits change the baseline you are working from.

There is also the psychological side. Many people find that hunger returning feels alarming after months of relative quiet. Knowing that this is expected, and having a plan for it, is itself protective. Understanding how tirzepatide affects appetite over time can help make sense of what happens when that effect is removed.

If you are weighing up whether the time is right to stop, or whether there is a clinical reason to carry on, guidance on when to come off Mounjaro covers the indicators prescribers look at. When you are ready to take that next step, our pages on how to come off Mounjaro and how to come off tirzepatide walk through the practical process in detail. And if you are currently on treatment and thinking ahead, speaking to a clinician is always the right first step, check your eligibility and start a free consultation with our prescribers to talk through your options.